Laboratory Products

Off and On: Advances in Nanoparticle and Protein Electrophoretic Mobility Measurements by MP-PALS in Batch and Online Modes

Aug 03 2015

Author: Steven Trainoff PhD, Daniel Some PhD on behalf of Wyatt Technology Corporation

Free to read

This article has been unlocked and is ready to read.

Download

***This is a Premium Content Article that needs to be unlocked for tables and graphs to be visible***

Nanoparticle formulations are ubiquitous throughout modern pharmaceutical development; from protein biotherapeutics and vaccine adjuvants through to virus-like particles and emerging novel drug delivery systems. However, developing these complex formulations and suspensions is a challenging process. Proteins and nanoparticles are often unstable in suspension, with aggregation a particularly pressing concern. Unchecked aggregation can reduce the bioavailability of a nanotherapeutic or, for proteins, even induce a dangerous immunogenic response in the patient. Developing a stable formulation is therefore critical to meeting performance, safety and commercial targets. 

Characterisation of the net molecular charge of proteins in solution is a key component in optimising formulation stability. Likewise, the zeta potential of nanoparticles is an essential predictor of stability. While conventional techniques for determining electrophoretic mobility (and hence net molecular charge or zeta potential) are generally able to analyse electrophoretic mobility of nanoparticles reliably in many formulations, they may fail under certain conditions such high-salt buffers, and are prone to damaging the sample when measuring proteins or other biomacromolecules. Massively Parallel Phase Analysis Light Scattering (MP-PALS) overcomes these challenges to provide reliable, reproducible and nondestructive electrophoretic mobility measurements of fragile biomolecules and other particles in practically all formulation buffers. 

This article explores the technological advantages of MP-PALS and its role across bio/nanopharmaceutical development. Case studies illustrate how automated MP-PALS enables rapid, high throughout analysis of electrophoretic mobility and particle size in formulation. Fluorescent particles that are usually unsuited to standard zeta potential analysis are readily characterised by MP-PALS. Data are also presented on new investigations into online coupling of MP-PALS with Size Exclusion Chromatography (SEC). This novel technique performs electrophoretic mobility measurements in real-time as samples are eluted from the SEC column, providing mobility measurements across the entire size distribution...

Free to read

This article has been unlocked and is ready to read.

Download


Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

analytica 2024

Apr 09 2024 Munich, Germany

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

AOCS Annual Meeting & Expo

Apr 28 2024 Montreal, Quebec, Canada

SETAC Europe

May 05 2024 Seville, Spain

View all events